Related Experiment Video
Updated: Feb 17, 2026

Incorporation of a Survivable Liver Biopsy Procedure in Mice to Assess Non-alcoholic Steatohepatitis NASH Resolution
Published on: April 16, 2019
Biochemical Scoring System for diagnosing Nonalcoholic Steatohepatitis
Mohammad Noor-E-Alam1, Shahinul Alam2, Akm Khorshed Alam2
1Department of Hepatology, Shaheed Suhrawardy Medical College Hospital, Dhaka, Bangladesh.
This study introduces a novel biochemical scoring system to aid in diagnosing nonalcoholic steatohepatitis (NASH). The system offers a non-invasive method for identifying patients with this liver condition.
Area of Science:
- Hepatology
- Biochemistry
- Diagnostic Medicine
Background:
- Nonalcoholic steatohepatitis (NASH) is a progressive liver disease with increasing prevalence.
- Accurate diagnosis of NASH is crucial for timely intervention and management.
- Current diagnostic methods can be invasive or lack specificity.
Purpose of the Study:
- To develop and validate a novel biochemical scoring system for the diagnosis of nonalcoholic steatohepatitis (NASH).
- To provide a non-invasive, cost-effective tool for identifying NASH.
Main Methods:
- Development of a scoring system based on specific biochemical markers.
- Validation of the scoring system using patient data.
- Comparison of the scoring system's performance against established diagnostic criteria.
Main Results:
- The proposed biochemical scoring system demonstrated significant accuracy in differentiating NASH from simple steatosis.
- Specific biochemical markers were identified as key predictors of NASH.
- The system showed potential as a reliable non-invasive diagnostic tool.
Conclusions:
- The developed biochemical scoring system offers a promising non-invasive approach for diagnosing nonalcoholic steatohepatitis (NASH).
- This tool can potentially reduce the need for liver biopsies in diagnosing NASH.
- Further validation in larger, diverse populations is warranted.
Related Concept Videos
Ultrasound II: Endoscopic Ultrasound and FibroScan
Endoscopic Ultrasound (EUS):
Effect of Hepatic Disease on Pharmacokinetics: Pathophysiologic Assessment and Liver Function Test

